
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1055 | 1046 | 1200 | 1370 | 1667 | 1914 |
Fund Return | 5.52% | 4.56% | 20.02% | 11.06% | 10.76% | 6.71% |
Place in category | 184 | 113 | 149 | 184 | 185 | 157 |
% in Category | 16 | 9 | 12 | 18 | 26 | 37 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Dividend Income GIF 1 | 1.14B | 1.23 | 5.26 | 6.92 | ||
Manulife RetPlus Div incm | 1.14B | 1.34 | 5.97 | 7.65 | ||
Manulife Dividend Income GIF 2 | 1.14B | 1.30 | 5.71 | 7.37 | ||
Manulife Div incm Sel InvPlus F | 1.14B | 1.56 | 7.39 | 9.03 | ||
Manulife RetPlus Div incm F | 1.14B | 1.50 | 7.04 | 8.73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 17.07B | -0.93 | 23.49 | - | ||
Capital Group Glbal Equity Fd F CAD | 13.56B | 2.07 | 11.83 | 10.97 | ||
Capital Group Glbal Equity Fd A CAD | 13.56B | 1.89 | 10.61 | 9.74 | ||
Capital Group Glbal Equity Fd D CAD | 13.56B | 2.03 | 11.47 | 10.50 | ||
EdgePoint Glbl Port non HST Sr A | 12.63B | 5.94 | 8.84 | 7.77 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Royal Bank of Canada 4.31% | XS2729223573 | 4.66 | - | - | |
Berkshire Hathaway B | US0846707026 | 3.79 | 523.14 | +0.02% | |
Alphabet A | US02079K3059 | 3.61 | 160.67 | -2.20% | |
Abbott Labs | US0028241000 | 3.51 | 126.30 | -1.05% | |
J&J | US4781601046 | 3.26 | 164.25 | +0.87% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Strong Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review